玻璃体内注射布罗珠单抗后发生的血管阻塞性视网膜病变 - Suppr

Suppr

超能文献

[Vaso-occlusive retinitis following intravitreal injection of brolucizumab].

作者信息

Angerer Maximillian Peter Michael, Neuburger Matthias, Hille Konrad, Horn Peter Christian

机构信息

Augenklinik, Ortenauklinikum Offenburg, Weingartenstr. 70, 77654, Offenburg, Deutschland.

Augenärzte Achern, Achern, Deutschland.

出版信息

Ophthalmologe. 2021 Oct;118(10):1048-1050. doi: 10.1007/s00347-020-01253-9. Epub 2020 Nov 3.

DOI:10.1007/s00347-020-01253-9

PMID:33141333

Abstract

摘要

相似文献

[Vaso-occlusive retinitis following intravitreal injection of brolucizumab].

Ophthalmologe. 2021 Oct;118(10):1048-1050. doi: 10.1007/s00347-020-01253-9. Epub 2020 Nov 3.

[Intraocular inflammation with occlusive retinal vasculitis following intravitreal injection of brolucizumab].

Ophthalmologe. 2022 Mar;119(3):296-299. doi: 10.1007/s00347-021-01341-4. Epub 2021 Feb 24.

[Bilateral occlusive vasculitis after intravitreal injection of brolucizumab in neovascular age-related macular degeneration].

Ophthalmologe. 2022 Jan;119(1):75-78. doi: 10.1007/s00347-021-01323-6. Epub 2021 Feb 11.

[Bilateral vasculitis following intravitreal brolucizumab injection].

Ophthalmologe. 2022 Jan;119(Suppl 1):93-97. doi: 10.1007/s00347-021-01330-7. Epub 2021 Feb 17.

Cytomegalovirus retinitis after intravitreal bevacizumab injection in an immunocompetent patient.

Korean J Ophthalmol. 2013 Feb;27(1):61-3. doi: 10.3341/kjo.2013.27.1.61. Epub 2013 Jan 9.

[Bilateral Vasculitis after Single Intravitreal Brolucizumab Injection].

Klin Monbl Augenheilkd. 2022 Feb;239(2):196-201. doi: 10.1055/a-1675-2829. Epub 2021 Dec 15.

Retinal vasculitis after intravitreal injection of brolucizumab.

Can J Ophthalmol. 2022 Apr;57(2):e40. doi: 10.1016/j.jcjo.2021.04.004. Epub 2021 May 7.

The combination therapy of subtenon triamcinolone acetonide injection and intravitreal brolucizumab for brolucizumab-related intraocular inflammation.

Medicine (Baltimore). 2021 Oct 22;100(42):e27580. doi: 10.1097/MD.0000000000027580.

Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER.

Ophthalmology. 2021 Jul;128(7):1050-1059. doi: 10.1016/j.ophtha.2020.11.011. Epub 2020 Nov 15.

Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab.

Ophthalmology. 2020 Oct;127(10):1345-1359. doi: 10.1016/j.ophtha.2020.04.017. Epub 2020 Apr 25.

引用本文的文献

Functional Outcomes of Brolucizumab-Induced Intraocular Inflammation Involving the Posterior Segment-A Meta-Analysis and Systematic Review.

J Clin Med. 2023 Jul 14;12(14):4671. doi: 10.3390/jcm12144671.

[Bilateral vasculitis following intravitreal brolucizumab injection].

Ophthalmologe. 2022 Jan;119(Suppl 1):93-97. doi: 10.1007/s00347-021-01330-7. Epub 2021 Feb 17.

[Intraocular inflammation with brolucizumab use : Patient management-diagnosis-therapy].

Ophthalmologe. 2021 Mar;118(3):248-256. doi: 10.1007/s00347-021-01321-8. Epub 2021 Feb 8.

本文引用的文献

Expert Opinion on Management of Intraocular Inflammation, Retinal Vasculitis, and Vascular Occlusion after Brolucizumab Treatment.

Ophthalmol Retina. 2021 Jun;5(6):519-527. doi: 10.1016/j.oret.2020.09.020. Epub 2020 Sep 29.

Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab.

J Vitreoretin Dis. 2020 Jul;4(4):269-279. doi: 10.1177/2474126420930863. Epub 2020 Jul 1.

Is This a 737 Max Moment for Brolucizumab?

Am J Ophthalmol. 2020 Aug;216:A7-A8. doi: 10.1016/j.ajo.2020.05.012. Epub 2020 May 25.

Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration.

Am J Ophthalmol Case Rep. 2020 Mar 31;18:100680. doi: 10.1016/j.ajoc.2020.100680. eCollection 2020 Jun.

Vancomycin-Associated Hemorrhagic Occlusive Retinal Vasculitis: Clinical Characteristics of 36 Eyes.

Ophthalmology. 2017 May;124(5):583-595. doi: 10.1016/j.ophtha.2016.11.042. Epub 2017 Jan 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Vaso-occlusive retinitis following intravitreal injection of brolucizumab].

Ophthalmologe. 2021 Oct;118(10):1048-1050. doi: 10.1007/s00347-020-01253-9. Epub 2020 Nov 3.

[Intraocular inflammation with occlusive retinal vasculitis following intravitreal injection of brolucizumab].

Ophthalmologe. 2022 Mar;119(3):296-299. doi: 10.1007/s00347-021-01341-4. Epub 2021 Feb 24.

[Bilateral occlusive vasculitis after intravitreal injection of brolucizumab in neovascular age-related macular degeneration].

Ophthalmologe. 2022 Jan;119(1):75-78. doi: 10.1007/s00347-021-01323-6. Epub 2021 Feb 11.

[Bilateral vasculitis following intravitreal brolucizumab injection].

Ophthalmologe. 2022 Jan;119(Suppl 1):93-97. doi: 10.1007/s00347-021-01330-7. Epub 2021 Feb 17.

Cytomegalovirus retinitis after intravitreal bevacizumab injection in an immunocompetent patient.

Korean J Ophthalmol. 2013 Feb;27(1):61-3. doi: 10.3341/kjo.2013.27.1.61. Epub 2013 Jan 9.

[Bilateral Vasculitis after Single Intravitreal Brolucizumab Injection].

Klin Monbl Augenheilkd. 2022 Feb;239(2):196-201. doi: 10.1055/a-1675-2829. Epub 2021 Dec 15.

Retinal vasculitis after intravitreal injection of brolucizumab.

Can J Ophthalmol. 2022 Apr;57(2):e40. doi: 10.1016/j.jcjo.2021.04.004. Epub 2021 May 7.

The combination therapy of subtenon triamcinolone acetonide injection and intravitreal brolucizumab for brolucizumab-related intraocular inflammation.

Medicine (Baltimore). 2021 Oct 22;100(42):e27580. doi: 10.1097/MD.0000000000027580.

Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER.

Ophthalmology. 2021 Jul;128(7):1050-1059. doi: 10.1016/j.ophtha.2020.11.011. Epub 2020 Nov 15.

Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab.

Ophthalmology. 2020 Oct;127(10):1345-1359. doi: 10.1016/j.ophtha.2020.04.017. Epub 2020 Apr 25.

引用本文的文献

Functional Outcomes of Brolucizumab-Induced Intraocular Inflammation Involving the Posterior Segment-A Meta-Analysis and Systematic Review.

J Clin Med. 2023 Jul 14;12(14):4671. doi: 10.3390/jcm12144671.

[Bilateral vasculitis following intravitreal brolucizumab injection].

Ophthalmologe. 2022 Jan;119(Suppl 1):93-97. doi: 10.1007/s00347-021-01330-7. Epub 2021 Feb 17.

[Intraocular inflammation with brolucizumab use : Patient management-diagnosis-therapy].

Ophthalmologe. 2021 Mar;118(3):248-256. doi: 10.1007/s00347-021-01321-8. Epub 2021 Feb 8.

本文引用的文献

Expert Opinion on Management of Intraocular Inflammation, Retinal Vasculitis, and Vascular Occlusion after Brolucizumab Treatment.

Ophthalmol Retina. 2021 Jun;5(6):519-527. doi: 10.1016/j.oret.2020.09.020. Epub 2020 Sep 29.

Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab.

J Vitreoretin Dis. 2020 Jul;4(4):269-279. doi: 10.1177/2474126420930863. Epub 2020 Jul 1.

Is This a 737 Max Moment for Brolucizumab?

Am J Ophthalmol. 2020 Aug;216:A7-A8. doi: 10.1016/j.ajo.2020.05.012. Epub 2020 May 25.

Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration.

Am J Ophthalmol Case Rep. 2020 Mar 31;18:100680. doi: 10.1016/j.ajoc.2020.100680. eCollection 2020 Jun.

Vancomycin-Associated Hemorrhagic Occlusive Retinal Vasculitis: Clinical Characteristics of 36 Eyes.

Ophthalmology. 2017 May;124(5):583-595. doi: 10.1016/j.ophtha.2016.11.042. Epub 2017 Jan 19.